These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. First isolation of Clostridium difficile PCR ribotype 027 from a patient with severe persistent diarrhoea in Hungary. Terhes G; Urbán E; Konkoly-Thege M; Székely E; Brazier JS; Kuijper EJ; Nagy E Clin Microbiol Infect; 2009 Sep; 15(9):885-6. PubMed ID: 19702592 [TBL] [Abstract][Full Text] [Related]
43. Transfer of Clostridium difficile Genetic Elements Conferring Resistance to Macrolide-Lincosamide-Streptogramin B (MLSB) Antibiotics. Barbanti F; Wasels F; Spigaglia P Methods Mol Biol; 2016; 1476():187-98. PubMed ID: 27507342 [TBL] [Abstract][Full Text] [Related]
48. Analysis of metronidazole susceptibility in different Clostridium difficile PCR ribotypes. Moura I; Spigaglia P; Barbanti F; Mastrantonio P J Antimicrob Chemother; 2013 Feb; 68(2):362-5. PubMed ID: 23104495 [TBL] [Abstract][Full Text] [Related]
49. Nosocomial diarrhea and Clostridium Difficile associated diarrhea in a Turkish University Hospital. Ergen EK; Akalin H; Yilmaz E; Sinirtaş M; Alver O; Heper Y; Ozakin C; Bakker D; Ener B; Mistik R; Helvaci S; Kuijper EJ Med Mal Infect; 2009 Jun; 39(6):382-7. PubMed ID: 19269761 [TBL] [Abstract][Full Text] [Related]
50. [Assessment of susceptibility of strictly anaerobic bacteria originated from different sources to fluoroquinolones and other antimicrobial drugs]. Lachowicz D; Skopińska E; Pawłowska J; Kostkiewicz M; Obuch-Woszczatyński P; Wultańska D; Pituch H Med Dosw Mikrobiol; 2012; 64(2):115-22. PubMed ID: 23072056 [TBL] [Abstract][Full Text] [Related]
51. Clostridium difficile isolates derived from Czech horses are resistant to enrofloxacin; cluster to clades 1 and 5 and ribotype 033 predominates. Kecerova Z; Cizek A; Nyc O; Krutova M Anaerobe; 2019 Apr; 56():17-21. PubMed ID: 30630037 [TBL] [Abstract][Full Text] [Related]
52. Antimicrobial susceptibility of Clostridium difficile by E test. Cheng SH; Chu FY; Lo SH; Lu JJ J Microbiol Immunol Infect; 1999 Jun; 32(2):116-20. PubMed ID: 11561576 [TBL] [Abstract][Full Text] [Related]
53. Comparative evaluation of VITEK 2 for antimicrobial susceptibility testing of group B Streptococcus. Tazi A; Réglier-Poupet H; Raymond J; Adam JM; Trieu-Cuot P; Poyart C J Antimicrob Chemother; 2007 Jun; 59(6):1109-13. PubMed ID: 17439974 [TBL] [Abstract][Full Text] [Related]
54. Antimicrobial susceptibility and mechanisms of resistance of Greek Clostridium difficile clinical isolates. Chatedaki C; Voulgaridi I; Kachrimanidou M; Hrabak J; Papagiannitsis CC; Petinaki E J Glob Antimicrob Resist; 2019 Mar; 16():53-58. PubMed ID: 30266640 [TBL] [Abstract][Full Text] [Related]